Medical/Pharmaceuticals APAC News & Press Release Distribution

Digital Health Platform Doctor Anywhere Closes S$88 Million Series C Round to Deepen Southeast Asia Expansion

* The company has experienced a 500 percent growth in the business since the start of 2020. * The investment will significantly bolster DA's market leadership and its mission to transform the regional healthcare landscape through technology. SINGAPORE, Aug. 31, 2021 /PRNewswire/ -- Doctor Any...

2021-08-31 10:00 9110

Digital Health Platform Doctor Anywhere Closes S$88 Million Series C Round to Deepen Southeast Asia Expansion

Organ transplants fell by a third worldwide during first wave of COVID-19 pandemic, new study presented at ESOT Congress 2021 shows

MILAN, Aug. 31, 2021 /PRNewswire/ -- The number of solid organ transplants performed during the first wave of COVID-19 in 2020 plunged by 31% compared to the previous year, according to a new global study presented at theEuropean Society for Organ Transplantation (ESOT) Congress 2021

2021-08-31 07:01 3088

Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2022

1Q22 Added 19,673 New Subscribers Revenues Up 12.2% YoY to RMB315.2 Million ($48.8 Million) Gross Profit Up 12.6% YoY to RMB267.3 Million ($41.4 Million) Operating Income Up 17.3% YoY to RMB156.6 Million ($24.2 Million) Non-GAAP Operating Income Up 15.5% YoY to RMB168.5 Million ($26.1 Million) Confe...

2021-08-31 04:16 5242

Thrombosis Research Institute (TRI) Shares Six New GARFIELD-AF And RIVER Real-world Data Analyses At ESC Congress 2021

- Four GARFIELD-AF e-posters shine light on managing atrial fibrillation (AF) in patients with clinically challenging conditions and diabetes, as well as on AF trial populations - Two RIVER e-posters provide two-year outcomes data and insights on appropriate dosing and renal function in patients...

2021-08-31 03:56 2973

LifeTech Scientific Corporation Announces 2021 Interim Results

SHENZHEN, China, Aug. 31, 2021 /PRNewswire/ -- LifeTech Scientific Corporation (LifeTech, 01302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 interim results. Compared with...

2021-08-31 03:46 6454

Viva Biotech Announced 2021 Interim Results

Revenue Increased by 419.5% YoY, CRO Business Income Increased by 62.5% YoY, O rderBacklog Recorded a Significant Increase of 72% Financial Highlights for the 6 months ended June 30, 2021: * Revenue amounted to RMB1,026.5 million, representing a year-on-year (YoY) increase of approximately 419...

2021-08-31 01:32 5848

Everest Medicines Announces Half-Year 2021 Interim Results

SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater C...

2021-08-30 22:15 5948

Everest Medicines Announces Up to HK$100 million Share Repurchase Program

SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced t...

2021-08-30 22:03 5120

Approval to Market Sofwave(TM) in South Korea

Key Regulatory Milestone in Company's International Growth Strategy for Unrivaled Ultrasound Technology Treating Fine Lines and Wrinkles YOQNEAM, Israel, Aug. 30, 2021 /PRNewswire/ -- Sofwave Medical LTD, today announced it has received approval from the Korean Ministry of Foods and Drug Safety ...

2021-08-30 20:30 3186

Zamst Announces Sponsorship with Wilfredo León Venero, a Polish Pro Volleyball Player

TOKYO, Aug. 30, 2021 /PRNewswire/ -- Nippon Sigmax Co., Ltd., a company owning "Zamst," a brand of athletic braces and care products headquartered inTokyo, Japan, announced a global sponsorship agreement with Wilfredo León Venero, men's professional volleyball player playing for the SIR Safety Pe...

2021-08-30 14:00 4393

Zamst Announces Sponsorship with Wilfredo León Venero, a Polish Pro Volleyball Player

NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth

STATE COLLEGE, Pa., Aug. 30, 2021 /PRNewswire/ -- NeuExcell Therapeutics ( www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $10+ million Series Pre-A financing round. The round was led by Co-Win Ventures, joined by other institutional investors Yua...

2021-08-30 13:00 2525

Alphamab Oncology Reports 2021 Interim Results and Business Highlights

SUZHOU, China, Aug. 30, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK), announced the company's interim results for the six months ended on June 30, 2021, and highlighted recent progress and upcoming milestones. Dr. Ting Xu, Chairman and CEO of Alphamab Oncology, commented, "In 2021 ...

2021-08-30 10:51 4816

Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test

HONG KONG, Aug. 30, 2021 /PRNewswire/ -- PHASE Scientific announces that its INDICAID™ COVID-19 Rapid Antigen Test (INDICAID™) has received Emergency Use Authorization from the Ministry of Health (MOH) of the Republic ofKenya on 17 August 2021. The authorization enables the test to be used in Ken...

2021-08-30 09:00 5052

Innovent to Present New Data on Sintilimab and Other Molecules at the European Society for Medical Oncology (ESMO) Congress 2021

SAN FRANCISCO and SUZHOU, China, Aug. 30, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2021-08-30 08:00 4544

Hope Medicine Inc. Announced Dr. Henri Nico Doods as Chief Executive Officer

SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical stage innovative biopharmaceutical company, has recently announced that the former President and Head of Research & Clinical Development, Dr.Henri Nico Doods, will serve as the company's Chief Executive Officer. Dr...

2021-08-30 08:00 8521

Hope Medicine Inc. Announced Dr. Henri Nico Doods as Chief Executive Officer

MediCap Sdn Bhd Achieves Over 50% of the RM2,000,000 Equity Crowdfunding Goal to Expand 5-in-1 Health Hubs

PETALING JAYA, Malaysia, Aug. 27, 2021 /PRNewswire/ -- MediCap Sdn Bhd (MediCap) has amassed RM1,025,000 in equity crowdfunding, over 50% of the minimum goal ofRM2,000,000 through MyStartr, Malaysia's leading equity crowdfunding platform approved by the Malaysia Security Commission, in a bid to ...

2021-08-27 09:00 4069

MediCap Sdn Bhd Achieves Over 50% of the RM2,000,000 Equity Crowdfunding Goal to Expand 5-in-1 Health Hubs

Innovent and Bolt Biotherapeutics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs

SAN FRANCISCO and SUZHOU, China, Aug. 27, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-08-27 08:00 5961

Lynk Pharmaceuticals announced the completion of Series B financing of $50 million

HANGZHOU, China, Aug. 27, 2021 /PRNewswire/ -- Lynk Pharmaceuticals CO., LTD (hereinafter referred to as "Lynk Pharmaceuticals"), an innovative pharmaceutical R&D company, today announced that it has successfully completed Series B financing of$50 million, with Lilly Asia Ventures (LAV) as lead ...

2021-08-27 08:00 6551

JNCCN Study Reveals Neuroendocrine Tumor Mortality Patterns to Inform Treatment Decisions

Population–based cohort study from Canada is first to describe patterns of mortality, both cancer-related and otherwise, for people with different types of NETs. PLYMOUTH MEETING, Pa., Aug. 27, 2021 /PRNewswire/ -- Among all patients with neuroendocrine tumors (NETs), the risk of dying of cancer...

2021-08-27 03:30 2269

Insilico Medicine and 4B Technologies Announce Strategic Collaboration in Advancing Novel Drug Discovery for Neurodegenerative Diseases

SHANGHAI, Aug. 27, 2021 /PRNewswire/ -- Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, and4B Technologies Co., Ltd. ("4B Technologies"), a leading end-to-end innovative biopharmaceutical company focusing on nervous system diseases, signed...

2021-08-27 03:22 32320